33749211000001103: Olaratumab (substance)

Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 01-Oct 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module

102541801000001118 Olaratumab (substance) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

102541901000001112 Olaratumab en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Olaratumab	Is a	Monoclonal antibody	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Olaratumab 500mg/50ml solution for infusion vials	Has specific active ingredient	False	Olaratumab	Inferred relationship	Existential restriction modifier
Lartruvo 500mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd)	Has specific active ingredient	False	Olaratumab	Inferred relationship	Existential restriction modifier
Olaratumab 500mg/50ml solution for infusion vials 1 vial	Has specific active ingredient	False	Olaratumab	Inferred relationship	Existential restriction modifier
Lartruvo 500mg/50ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial	Has specific active ingredient	False	Olaratumab	Inferred relationship	Existential restriction modifier
Olaratumab 190mg/19ml solution for infusion vials	Has specific active ingredient	False	Olaratumab	Inferred relationship	Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd)	Has specific active ingredient	False	Olaratumab	Inferred relationship	Existential restriction modifier
Olaratumab 190mg/19ml solution for infusion vials 1 vial	Has specific active ingredient	False	Olaratumab	Inferred relationship	Existential restriction modifier
Lartruvo 190mg/19ml concentrate for solution for infusion vials (Eli Lilly and Company Ltd) 1 vial	Has specific active ingredient	False	Olaratumab	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets